glp 1 oral med GLP-1s: benefits beyond weight loss Clinically backed oral GLP FinancialContent - Best Weight Loss

Rather, discovery work like this is risky, slow, and uncertain

Another meta-analysis (July 2025), looking only at endoscopies, found an increased incidence of pulmonary aspiration among patients taking GLP-1 RAs (OR 2.29, 95% CI 1.36-3.87)

Reduced efficacy concerns GLP-1 receptor agonists are designed to work at specific doses to achieve optimal receptor activation (saturation) and to provide full therapeutic effect

There is no universal recommendation for baseline testing or fixed monitoring intervals unless locally commissioned

10.1016/j.tips.2004.03.005 38 HonkuraY.MatsuoH.MurakamiS.SakiyamaM.MizutariK.ShiotaniA.et al (2016)